CARNITENE

This brand name is authorized in Croatia, Estonia, Hong Kong SAR China, Italy, Netherlands.

Active ingredients

The drug CARNITENE contains one active pharmaceutical ingredient (API):

1	L-carnitine UNII 0G389FZZ9M - LEVOCARNITINE
	Levocarnitine as a factor is necessary in the transport of long-chain fatty acids into the mitochondria-facilitating the oxidation of fatty acids rather than their incorporation into triglycerides.
	Read more about L-carnitine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A16AA01	Levocarnitine	A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AA Amino acids and derivatives
Discover more medicines within A16AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1153561, 1238914, 1621471, 1777619, 1782132
HK	Department of Health Drug Office	36344
HR	Agencija za lijekove i medicinske proizvode	HR-H-024622959, HR-H-412161189
IT	Agenzia del Farmaco	018610079
NL	Z-Index G-Standaard	12822353, 12822361
NL	Z-Index G-Standaard, PRK	23337, 23345, 24716